Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor

Arch Neurol. 1973 Feb;28(2):107-10. doi: 10.1001/archneur.1973.00490200055007.
No abstract available

MeSH terms

  • Aged
  • Aromatic Amino Acid Decarboxylase Inhibitors*
  • Basal Ganglia / metabolism
  • Brain / metabolism*
  • Brain Chemistry
  • Caudate Nucleus / metabolism
  • Cerebellar Cortex / metabolism
  • Cerebral Cortex / metabolism
  • Dihydroxyphenylalanine / adverse effects
  • Dihydroxyphenylalanine / therapeutic use*
  • Dopamine / metabolism*
  • Female
  • Humans
  • Hydrazines / therapeutic use*
  • Hypothalamus / metabolism
  • Male
  • Middle Aged
  • Norepinephrine / metabolism*
  • Palladium / metabolism
  • Parkinson Disease / metabolism*
  • Parkinson Disease / pathology
  • Phenylacetates / metabolism
  • Substantia Nigra / metabolism
  • Thalamus / metabolism

Substances

  • Aromatic Amino Acid Decarboxylase Inhibitors
  • Hydrazines
  • Phenylacetates
  • Palladium
  • Dihydroxyphenylalanine
  • Dopamine
  • Norepinephrine